IL94256A - History of the novel, the process of making them and the preparations of the medicines that contain them - Google Patents

History of the novel, the process of making them and the preparations of the medicines that contain them

Info

Publication number
IL94256A
IL94256A IL9425690A IL9425690A IL94256A IL 94256 A IL94256 A IL 94256A IL 9425690 A IL9425690 A IL 9425690A IL 9425690 A IL9425690 A IL 9425690A IL 94256 A IL94256 A IL 94256A
Authority
IL
Israel
Prior art keywords
formula
dihydro
oxo
oxy
alkyl
Prior art date
Application number
IL9425690A
Other languages
English (en)
Hebrew (he)
Other versions
IL94256A0 (en
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL94256A0 publication Critical patent/IL94256A0/xx
Publication of IL94256A publication Critical patent/IL94256A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9425690A 1989-06-02 1990-05-02 History of the novel, the process of making them and the preparations of the medicines that contain them IL94256A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918041A DE3918041A1 (de) 1989-06-02 1989-06-02 Chromanderivate

Publications (2)

Publication Number Publication Date
IL94256A0 IL94256A0 (en) 1991-03-10
IL94256A true IL94256A (en) 1994-04-12

Family

ID=6381944

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9425690A IL94256A (en) 1989-06-02 1990-05-02 History of the novel, the process of making them and the preparations of the medicines that contain them

Country Status (20)

Country Link
US (1) US5112972A (fr)
EP (1) EP0400430B1 (fr)
JP (1) JPH0320275A (fr)
KR (1) KR910000713A (fr)
AR (1) AR245715A1 (fr)
AT (1) ATE110072T1 (fr)
AU (1) AU623780B2 (fr)
CA (1) CA2017961A1 (fr)
DE (2) DE3918041A1 (fr)
DK (1) DK0400430T3 (fr)
ES (1) ES2057262T3 (fr)
FI (1) FI95701C (fr)
HU (1) HUT58323A (fr)
IE (1) IE65098B1 (fr)
IL (1) IL94256A (fr)
NO (1) NO175976C (fr)
NZ (1) NZ233912A (fr)
PT (1) PT94225B (fr)
TW (1) TW210338B (fr)
ZA (1) ZA904227B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
CA2153498A1 (fr) * 1993-11-10 1995-05-18 Hidetsura Cho Derive de chromanne et utilisation therapeutique de ce dernier
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
WO2001021609A1 (fr) * 1999-09-24 2001-03-29 Nissan Chemical Industries, Ltd. Derive de 4-oxybenzopyranne
AU7453900A (en) * 1999-10-05 2001-05-10 Nissan Chemical Industries Ltd. 4-oxybenzopyran derivative
CA2505500C (fr) 2002-11-12 2009-08-18 Warner-Lambert Company Llc Methodes de stimulation de la croissance des cheveux au moyen de benzopyranes
CA2589363A1 (fr) * 2004-12-13 2006-06-22 Eli Lilly And Company Derives spiro utilises en tant qu'inhibiteurs de lipoxygenase
US7812183B2 (en) 2005-09-01 2010-10-12 Janssen Pharmaceutica Nv Benzopyran derivatives as potassium channel openers
WO2024040267A2 (fr) * 2022-08-19 2024-02-22 Mitokinin, Inc. Synthèse directe de n-(3-substitué-chroman-4-yl) -7 h-pyrrolo [2,3-d] pyrimidin-4-amines et de leurs dérivés

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE23718T1 (de) * 1981-09-25 1986-12-15 Beecham Group Plc Benzopyran-verbindungen mit pharmazeutischer wirkung.
DE3364145D1 (de) * 1982-04-08 1986-07-24 Beecham Group Plc Antihypertensive benzopyranols
EP0093534A1 (fr) * 1982-04-28 1983-11-09 Beecham Group Plc Chromanols
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (fr) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Dérivés de chromane

Also Published As

Publication number Publication date
JPH0320275A (ja) 1991-01-29
NO902459L (no) 1990-12-03
IE901988L (en) 1990-12-02
TW210338B (fr) 1993-08-01
FI95701C (fi) 1996-03-11
DK0400430T3 (da) 1994-09-12
NO175976C (no) 1995-01-11
IL94256A0 (en) 1991-03-10
DE59006817D1 (de) 1994-09-22
EP0400430B1 (fr) 1994-08-17
DE3918041A1 (de) 1990-12-06
HU903293D0 (en) 1990-10-28
AR245715A1 (es) 1994-02-28
AU623780B2 (en) 1992-05-21
ES2057262T3 (es) 1994-10-16
NO902459D0 (no) 1990-06-01
CA2017961A1 (fr) 1990-12-02
EP0400430A3 (fr) 1991-01-02
KR910000713A (ko) 1991-01-30
PT94225A (pt) 1991-02-08
EP0400430A2 (fr) 1990-12-05
ATE110072T1 (de) 1994-09-15
ZA904227B (en) 1991-03-27
FI95701B (fi) 1995-11-30
US5112972A (en) 1992-05-12
IE901988A1 (en) 1991-01-02
HUT58323A (en) 1992-02-28
NZ233912A (en) 1992-10-28
FI902727A0 (fi) 1990-06-01
AU5600790A (en) 1990-12-06
IE65098B1 (en) 1995-10-04
PT94225B (pt) 1996-12-31
NO175976B (no) 1994-10-03

Similar Documents

Publication Publication Date Title
JP2523343B2 (ja) クロマン誘導体
US5013853A (en) Chroman derivatives
US5387587A (en) Chroman derivatives
US5112972A (en) Synthesis of chroman derivatives
US5130322A (en) Chroman derivatives
US5143924A (en) Oxodihydropyridyl chroman derivatives
AU626549B2 (en) Chroman derivatives
US5132307A (en) Tetralin compounds
US5112839A (en) Chroman derivatives
AU628395B2 (en) Chroman derivatives
AU645373B2 (en) Chroman derivatives
US5036068A (en) 4-(pyridyl)- and 4-(oxo-pyridyl)-1,3-benzoxazines
US5232944A (en) Chroman derivatives
CA2022693A1 (fr) Derives de chroman
CA2027097A1 (fr) Derives de chromane

Legal Events

Date Code Title Description
RH Patent void